Altimmune (ALT) said Thursday it will be added to the Nasdaq Biotechnology Index before trading begins on Dec. 23.
The company said the index is designed to track the performance of biotechnology and pharmaceutical companies listed on the Nasdaq stock exchange and serves as the basis for the iShares Nasdaq Biotechnology Index Fund.
Shares of the company were up 4.6% in recent trading.
Price: 8.26, Change: +0.36, Percent Change: +4.56
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments